The Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBP
Clinical trial NCT06390306 · RECRUITING
Trial details
- NCT number
- NCT06390306
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.